Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 7,039

Document Document Title
WO/2014/083911A1
A method for producing a cyclopentanone derivative represented by general formula (III), wherein a cyclopentanone derivative represented by general formula (III) can be produced with higher yield since the method comprises a step wherein...  
WO/2014/083935A1
The present invention addresses the problem of providing a method that produces a higher yield of a carbonyl compound. In this production method for a carbonyl compound, dealkoxycarbonylation of a compound represented by formula (II) is ...  
WO/2014/083186A3
There is provided a compound comprising the general structure (I) in which, X is N or O; R3 is OR4 or R4; wherein when X is N, R1 is H, R5 or OR6; R2 is OC(O)R7; and R4 is R5, OR5 or aryl, which is unsubstituted or substituted with at le...  
WO/2014/083186A2
There is provided a compound comprising the general structure (I) in which, X is N or O; R3 is OR4 or R4; wherein when X is N, R1 is H, R5 or OR6; R2 is OC(O)R7; and R4 is R5, OR5 or aryl, which is unsubstituted or substituted with at le...  
WO/2014/080876A1
A method for producing GL, which is provided with: step (1) wherein a GAO composition, which preferably contains a high-boiling-point organic solvent or a solubilizing agent, is supplied into a reaction container and heated to a temperat...  
WO/2014/081558A1
Disclosed is a process for making diastereomeric N-sulfinyl α-amino amides by reaction of chiral sulfinimines with formamides and lithium diisopropylamide. The process of the invention provides the N-sulfinyl α-amino amides in high yie...  
WO/2014/074365A1
The present invention provides compounds of Formula I. Wherein Rl, L, and A are as described herein, or a pharmaceutical salt thereof, processes for preparing the compounds, and methods of treating a condition, such as hypertriglyceridem...  
WO/2014/072453A1
The present invention relates to a process for obtaining simultaneously several compositions comprising fatty acid alkyl esters (biodiesel), glycerol formal and fatty acid glycerol formal esters.  
WO/2014/065293A1
A liquid-crystal composition exhibiting an optically isotropic liquid crystal phase, and containing a chiral agent and an achiral component (T) which contains one or more types of a compound (1) having: a dioxane ring which is unsubstitu...  
WO/2014/064160A1
The present invention relates to a process for preparing cyclic carboxylic esters, especially intramolecular lactones, for example dilactide, wherein these cyclic esters are prepared from oligomeric carboxylic acids by cyclizing depolyme...  
WO/2014/054391A1
A compound represented by general formula (1). In general formula (1), R1 represents either one of a protective group for a hydroxy group and a hydrogen atom, and R2 and R3 independently represent a protective group for an amino group.  
WO/2014/053694A1
Compounds of formula I, wherein A, B, X, Z and R1-R6, are as defined in the claims, exhibit TRPA 1 activity and are thus useful as TRPA1 modulators.  
WO/2014/046193A1
Provided are: an organocopper complex having a structure represented by general formula (1); a copper oxide thin film comprising the organocopper complex; a method for producing the copper oxide thin film; and a compound constituting the...  
WO/2014/041059A1
The invention provides a process for the production of a compound of formula (I), said process comprising reacting a compound of formula (II) with a compound of formula (III) wherein R1 and R2 may be the same or different and are selecte...  
WO/2014/041058A1
The invention provides a process for the production of 1 a compound of formula (I), said process comprising reacting a compound of formula (II), with a compound of formula (III), wherein R1 and R2 may be the same or different and are sel...  
WO/2014/036766A1
Provided is a smectic phase A liquid crystal material, comprising a heterocyclic compound; the heterocycle is a nitrogen-containing heterocycle formed by replacing 1-4 carbon atoms in a benzene ring with nitrogen atoms, or a heterocycle ...  
WO/2014/033046A1
The invention relates to a process for preparing compounds containing isocyanate groups and cyclic carbonate structures, by reacting at least A) a monomeric diisocyanate with aliphatically, cycloaliphatically, araliphatically and/or arom...  
WO/2014/030820A1
The present invention provides a method for directly preparing lactide through the dehydration reaction of lactic acid in the presence of a catalyst containing a tin compound, preferably a tetravalent compound. The method of the present ...  
WO/2014/028487A1
Provided herein are lipidoids that may be prepared from the conjugate addition of alkylamines to acrylates. In some embodiments, provided lipidoids are biodegradable and may be used in a variety of drug delivery systems. Given the amino ...  
WO/2014/011120A1
The present invention generally relates to processes and methods for the synthesis of endoperoxide compounds. More specifically, the invention relates to a method for preparing endoperoxide compounds starting from an aryl imine of formul...  
WO/2014/000277A1
A method for using a recycled polylactic acid to prepare lactide is provided. The method comprises the following steps: A) crushing recycled polylactic acid material through a crusher; B) melting: melting and extruding the crushed recycl...  
WO/2013/185740A1
The invention relates to a method of preparation of 2-amino-2-[2-(4-octylphenyl)- ethyl]propane-1,3-diol (I), comprising opening of the aziridine ring of the intermediates (LVI) by the treatment with organometallic compounds, preferably ...  
WO/2013/184898A1
In one aspect, the invention relates to compounds having the formula X where Ra, Rb, R2, R7, and X are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds described herein are prodrugs of compoun...  
WO/2013/177223A1
Provided are synthetic dendrimer calibrants for mass spectrometry. The calibrants are distinguished by their relative ease and rapidity of synthesis, comparatively low cost, long shelf life, high purity, and amenability to batch synthesi...  
WO/2013/171318A1
The present invention relates to compounds of the formula (I), wherein the residues A, R1 to R5, Z1 and Z2 have the meanings indicated in the claims. The compounds of the formula (I) are valuable pharmacologically active compounds for us...  
WO/2013/168642A1
Provided is an industrial production method with which a substituted benzoic acid compound that is useful as a drug or agrichemical intermediate is obtained with high purity and at a high yield. A compound represented by formula (II) (wh...  
WO/2013/160485A1
The subject-matter of the present invention relates to a process for the continuous, heterogeneously catalysed, direct preparation of L-lactide from concentrated lactic acid. The aim is to circumvent the process steps of the known prepol...  
WO/2013/160418A1
The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammator...  
WO/2013/158302A1
The invention provides derivatives of DEA which have increased potency and hydrolysis resistance as compared to DEA, and compositions thereof, as well as methods of using these derivatives to promote neurogenesis, neurite growth and/or l...  
WO/2013/157528A1
Provided is a medicinal agent comprising a compound represented by general formula (1), a pharmaceutically acceptable salt of the compound or a solvate of the compound or the pharmaceutically acceptable salt. A compound represented by ge...  
WO/2013/150457A1
The object of the present invention relates to a composition that can be used as fuel comprising: at least one hydrocarbon mixture at least one hydrophobic ketal or acetal of glycerine. Said composition can be advantageously used as fuel...  
WO/2013/140969A1
The present invention is a photoresist composition which contains [A] a polymer that has a structural unit (I) containing an acid-cleavable group and a compound (I) that is represented by formula (1). In formula (1), each of R1, R2, R3 a...  
WO/2013/140347A1
Sulphonamide derivatives of benzylamine of formula (I), wherein A represents phenyl unsubstituted or substituted;or 9-or 10-membered bicyclic group, linked to –(O) x - (CH 2 ) y -through one of its aromatic carbon atoms,consisting of b...  
WO/2013/133377A1
Disclosed is a method for producing a lactide using a pyridinium-based catalyst, the method involving esterifying the carboxyl group of a lactic acid oligomer by means of a specific primary alcohol and heating the esterified product thus...  
WO/2013/131901A1
The present invention relates to a combination comprising compounds of formula (I): wherein R1to R3, A, X and n are as defined herein, and an additional active agent. The present invention also relates pharmaceutical compositions compris...  
WO/2013/134226A1
The present invention relates to compounds of formula (I) wherein R1 to R3, A, X and n are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorder. ...  
WO/2013/130792A3
Fluorinated prodrug compounds as can be used for selective streptococcal mevalonate pathway inhibition.  
WO/2013/130792A2
Fluorinated prodrug compounds as can be used for selective streptococcal mevalonate pathway inhibition.  
WO/2013/124363A3
The invention relates to a composition for the oxidative colouring of keratin-containing fibres, in particular human hair, which comprises at least one compound of the formula (I) as oxidation dye precursor of the developer-type.  
WO/2013/125356A1
Provided are: a liquid crystal compound which has high stability with respect to heat, light and the like, high clearing point, low lower limit temperature of the liquid crystal phase, low viscosity, adequate optical anisotropy, large di...  
WO/2013/123222A1
The invention provides processes for preparing intermediates useful for preparing compounds of the formula (IV): or a tautomer or salt thereof, where R1-R5, a, b, X and P2, are as defined in the specification.  
WO/2013/121209A1
A compound of formula I, and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: (Formula (I)) wherein either Q1, CR6a and optionally R6b together form a cyclic moiety whe...  
WO/2013/118907A1
An amide compound represented by formula (I) has an excellent pest control effect. (In the formula, Y represents a 3-7 membered saturated heterocyclic ring which contains, as ring-forming component(s), one or more atoms or groups that ar...  
WO/2013/108514A1
A production method for a compound indicated by general formula (V), including a step in which a compound indicated by general formula (II) is obtained by reacting a compound indicated by general formula (I) with an acid. (G1 and G2 each...  
WO/2013/088686A1
This adhesive resin composition contains a foaming adhesive polymer having a structure derived from a Meldrum's acid derivative, or a Meldrum's acid derivative represented by general formula (1) and an adhesive resin.  
WO/2013/083718A1
The present invention relates to a process for the preparation of a precursor for the synthesis of hexanoic acid derived statins and to the use of said precursor in the manufacture of a medicament.  
WO/2013/083719A1
The present invention relates to a process for the preparation of a precursor for the synthesis of hexanoic acid derived statins and to the use of said precursor in the manufacture of a medicament.  
WO/2013/079397A1
Disclosed are certain fluorinated derivatives of Meldrum's acid as novel compounds, preparation methods for the same, their use in Li ion batteries, Li air batteries and Li sulphur batteries as well as solvent compositions, electrolyte c...  
WO/2013/077719A1
The present invention relates to a molecule obtained from Krameria cytisoides for the treatment of inflammatory conditions. Specifically, the present invention relates to a cyclic polymer peroxide having anti-inflammatory pharmacological...  
WO/2013/059194A1
The disclosed subject matter provides certain N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In partic...  

Matches 51 - 100 out of 7,039